Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.
Korobelnik JF, Lanzetta P, Wykoff CC, Wong TY, Zhang X, Morgan-Warren P, Fitzpatrick S, Leal S, Brunck L, Hasanbasic Z, Chu KW, Reed K, Sivaprasad S. Korobelnik JF, et al. Among authors: morgan warren p. Eye (Lond). 2024 Dec;38(17):3218-3221. doi: 10.1038/s41433-024-03312-w. Epub 2024 Aug 31. Eye (Lond). 2024. PMID: 39217260 Free PMC article. No abstract available.
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.
Sivaprasad S, Ghanchi F, Kelly SP, Kotagiri A, Talks J, Scanlon P, McGoey H, Nolan A, Saddiq M, Napier J, Morgan-Warren P. Sivaprasad S, et al. Among authors: morgan warren p. Eye (Lond). 2023 Aug;37(12):2527-2534. doi: 10.1038/s41433-022-02367-x. Epub 2023 Jan 18. Eye (Lond). 2023. PMID: 36653595 Free PMC article.
Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis.
Sivaprasad S, Bailey C, Downey L, Gilbert R, Gale R, Kotagiri A, Mahmood S, Morgan-Warren P, Napier J, Narendran N, Pearce I, Rennie C, Talks J, Wojcik R, Jandhyala R. Sivaprasad S, et al. Among authors: morgan warren p. Curr Med Res Opin. 2024 Jul;40(7):1221-1233. doi: 10.1080/03007995.2024.2362278. Epub 2024 Jun 12. Curr Med Res Opin. 2024. PMID: 38814914 Review.
Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept.
Narendran N, Bailey C, Downey L, Gale R, Kotagiri A, Pearce I, Rennie CA, Sivaprasad S, Talks J, Morgan-Warren P, Napier J, O'Neil C, Seeborne T. Narendran N, et al. Among authors: morgan warren p. Clin Ophthalmol. 2024 Nov 2;18:3133-3142. doi: 10.2147/OPTH.S481772. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39512482 Free PMC article.
2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort.
Bailey C, Chandran M, Gale R, Narendran N, Talks J, McGoey H, Keshk Z, Morgan-Warren P, Allmeier H, Machewitz T, Patel PJ, Varma D. Bailey C, et al. Among authors: morgan warren p. Eye (Lond). 2024 Dec 24. doi: 10.1038/s41433-024-03550-y. Online ahead of print. Eye (Lond). 2024. PMID: 39719502
Practical implementation of a q4-q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panel.
Bailey C, Cackett P, Kotagiri A, Mahmood S, Minos E, Narendran N, Patwardhan A, Sim DA, Morgan-Warren P, O'Neil C, Straw K. Bailey C, et al. Among authors: morgan warren p. Eye (Lond). 2023 Jun;37(9):1916-1921. doi: 10.1038/s41433-022-02264-3. Epub 2022 Oct 7. Eye (Lond). 2023. PMID: 36207506 Free PMC article.
26 results